Dianthus Therapeutics
DNTH
DNTH
72 hedge funds and large institutions have $67.4M invested in Dianthus Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
Holders
72
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.19M | |
| 2 | +$5.06M | |
| 3 | +$524K | |
| 4 |
Millennium Management
New York
|
+$310K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$159K |
Top Sellers
| 1 | -$2.95M | |
| 2 | -$577K | |
| 3 | -$460K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$227K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$213K |